Clinical trials
Cardiac Allograft Vasculopathy clinical trials
Below are recruiting cardiac allograft vasculopathy clinical trials, each written for real people, not researchers. We’re tracking 4 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05826444Recruiting
Study of heart transplant micro-vessel disease using special tests
This trial is for people who have had a heart transplant and are having symptoms or need routine invasive check-ups. It tests an approach aimed at better understanding and monitoring “micro-vessel” problems in the transplanted heart.
BerlinAges Any age - NCT06089486Recruiting
New Heart Scan for Transplant Patients
This study investigates a new heart scan (called a cardiac PET) to detect early signs of blood vessel disease in heart transplant patients. If you had your transplant 2 to 10 years ago, this scan might be an alternative to the usual yearly checkup with an invasive procedure (angiogram).
Calgary, AlbertaAges 18 years+ - NCT04770012RecruitingPhase 3
Aspirin or clopidogrel after heart transplant
This study tests antiplatelet medicines (like aspirin or clopidogrel) in people who have had a heart transplant. The goal is to see if these medicines can safely help prevent blood-related complications after transplant.
Vancouver, British ColumbiaAges 18 years+ - NCT02798731Recruiting
Testing blood vessel function after a heart transplant
This trial measures how well tiny blood vessels in the heart are working in people who have had a heart transplant. It may help doctors understand transplant-related circulation problems and guide future care.
SeoulAges 18–85
Hear when a new Cardiac Allograft Vasculopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cardiac allograft vasculopathy?
- Yes. Clin2 currently lists 4 recruiting cardiac allograft vasculopathy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cardiac allograft vasculopathy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cardiac allograft vasculopathy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.